Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Five-lipoxygenase pathway of arachidonic acid metabolism in carcino-genesis and cancer chemoprevention.

Chen X, Sood S, Yang CS, Li N, Sun Z.

Curr Cancer Drug Targets. 2006 Nov;6(7):613-22. Review.

PMID:
17100567
2.
3.

Lipoxygenase inhibitors for cancer prevention: promises and risks.

Menna C, Olivieri F, Catalano A, Procopio A.

Curr Pharm Des. 2010;16(6):725-33. Review.

PMID:
20388082
4.

Inhibitors of the 5-lipoxygenase pathway in atherosclerosis.

Bäck M.

Curr Pharm Des. 2009;15(27):3116-32. Review.

PMID:
19754386
5.

Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation.

Nieves D, Moreno JJ.

Biochem Pharmacol. 2006 Oct 16;72(8):1022-30. Epub 2006 Aug 28.

PMID:
16934759
6.

[Leukotrienes: potential therapeutic targets in cardiovascular diseases].

Bäck M.

Bull Acad Natl Med. 2006 Oct;190(7):1511-8; discussion 1518-21. Review. French.

PMID:
17450683
7.

Lipoxygenase modulation to reverse carcinogenesis.

Shureiqi I, Lippman SM.

Cancer Res. 2001 Sep 1;61(17):6307-12. Review.

8.

Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis.

Hyde CA, Missailidis S.

Int Immunopharmacol. 2009 Jun;9(6):701-15. doi: 10.1016/j.intimp.2009.02.003. Epub 2009 Feb 23. Review.

PMID:
19239926
10.

Leukotriene B4.

Crooks SW, Stockley RA.

Int J Biochem Cell Biol. 1998 Feb;30(2):173-8. Review.

PMID:
9608670
11.

Leukotriene A4 hydrolase as a target for cancer prevention and therapy.

Chen X, Wang S, Wu N, Yang CS.

Curr Cancer Drug Targets. 2004 May;4(3):267-83. Review.

PMID:
15134534
12.

Potential use of lipoxygenase inhibitors for cancer chemoprevention.

Steele VE, Holmes CA, Hawk ET, Kopelovich L, Lubet RA, Crowell JA, Sigman CC, Kelloff GJ.

Expert Opin Investig Drugs. 2000 Sep;9(9):2121-38. Review.

PMID:
11060797
13.
14.

[Ammonium bituminosulfonate (Ichthyol). Anti-inflammatory effect and inhibition of the 5-lipoxygenase enzyme].

Diezel W, Schewe T, Rohde E, Rosenbach T, Czarnetzki BM.

Hautarzt. 1992 Dec;43(12):772-4. German.

PMID:
1361926
15.

Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade.

Tavolari S, Bonafè M, Marini M, Ferreri C, Bartolini G, Brighenti E, Manara S, Tomasi V, Laufer S, Guarnieri T.

Carcinogenesis. 2008 Feb;29(2):371-80. Epub 2007 Nov 21.

PMID:
18033773
16.

Leukotriene B4 in the immune system.

Claesson HE, Odlander B, Jakobsson PJ.

Int J Immunopharmacol. 1992 Apr;14(3):441-9. Review.

PMID:
1319964
17.

Eugenol--the active principle from cloves inhibits 5-lipoxygenase activity and leukotriene-C4 in human PMNL cells.

Raghavenra H, Diwakr BT, Lokesh BR, Naidu KA.

Prostaglandins Leukot Essent Fatty Acids. 2006 Jan;74(1):23-7. Epub 2005 Oct 7.

PMID:
16216483
18.

Lipoxygenase inhibitors as potential cancer chemopreventives.

Steele VE, Holmes CA, Hawk ET, Kopelovich L, Lubet RA, Crowell JA, Sigman CC, Kelloff GJ.

Cancer Epidemiol Biomarkers Prev. 1999 May;8(5):467-83. Review.

19.

Ethanol promotes chemically induced oral cancer in mice through activation of the 5-lipoxygenase pathway of arachidonic acid metabolism.

Guo Y, Wang X, Zhang X, Sun Z, Chen X.

Cancer Prev Res (Phila). 2011 Nov;4(11):1863-72. doi: 10.1158/1940-6207.CAPR-11-0206. Epub 2011 Aug 31.

20.

5-Lipoxygenase activation in psoriasis: a dead issue?

Ford-Hutchinson AW.

Skin Pharmacol. 1993;6(4):292-7. Review.

PMID:
8198815

Supplemental Content

Support Center